InvestorsHub Logo
Followers 229
Posts 22046
Boards Moderated 4
Alias Born 09/16/2011

Re: None

Wednesday, 10/16/2019 11:33:50 AM

Wednesday, October 16, 2019 11:33:50 AM

Post# of 2200
$TTNP - Titan Pharmaceuticals Shares Down 52% on Public Offering TTNP

11:00 AM ET 10/16/19 | Dow Jones


By Chris Wack

Shares of Titan Pharmaceuticals Inc. (TTNP) dropped 52%, to 18 cents, after the company said a public offering priced Wednesday.

The commercial-stage therapeutics company said an underwritten public offering of 40 million units priced to the public at 22.5 cents a unit.

Titan said each unit issued in the offering consists of one share of common stock and one Class B Warrant to purchase one share of common stock.

The company said gross proceeds are expected to be $9 million.

The Class B Warrants will be immediately exercisable at a price of 22.5 a share of common stock and will expire five years from the date of issuance.

The offering is expected to close on or about Oct. 18.

Write to Chris Wack at chris.wack@wsj.com

> Dow Jones Newswires

October 16, 2019 11:00 ET (15:00 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.